Mitochondrial disease and innate immunity: pathogenesis, risk factors and population history

Description of the granted funding

Did you know that every 1 in 88 people in Finland carries the genetic mutation for MIRAS – Mitochondrial Recessive Ataxia Syndrome? The MIRAS chromosome is spread around the world, the European ancestor dating to viking-times. MIRAS is a severe neurodegenerative disease manifesting at different ages and symptoms - from teenage epilepsy to middle-age parkinsonism. No cure exits for the disease. The identical genetic background in the patients implies that strong unknown risk or protective factors contribute to mechanism of disease. In this research plan, we explore those factors, utilizing state-of-art molecular methods and disease models already generated in the lab. We will explore mechanisms why MIRAS-chromosome was globally preserved through history, proposing and testing whether heterozygous carriership provided protection against environmental stresses. Identification of contributing factors are important targets for intervention, to minimise the impact of MIRAS.
Show more

Starting year

2021

End year

2024

Granted funding

Yilin Kang Orcid -palvelun logo
312 684 €

Funder

Research Council of Finland

Funding instrument

Postdoctoral Researcher

Other information

Funding decision number

340517

Fields of science

Biochemistry, cell and molecular biology

Research fields

Solu- ja molekyylibiologia

Identified topics

genes, genetics